Frazier Lifesciences Acquisition Corp
FLACDelisted Nov 22, 2022- Industry
- Blank Checks
- SEC CIK
- 0001828326
Frazier Lifesciences Acquisition Corp was delisted on Nov 22, 2022; its insiders filed their last Form 4 on Nov 25, 2022; 52 institutions reported holding it in 13F filings for Q3 2022, worth $102.2M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Frazier Lifesciences Acquisition Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 51 | 1 | 52 | +2 |
| Shares | 9.85M | 64.1K | 10.2M | +458.0K (+4.7%) |
| Value | $97.3M | $633.0K | $102.2M | +$5.51M (+5.7%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Frazier Lifesciences Acquisition Corp at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cubist Systematic Strategies, LLC | 380,500 | $3.79M | 0.03% |
| Rpo LLC | 195,000 | $1.94M | 0.51% |
| BNP Paribas Arbitrage, SA | 125,000 | $1.25M | 0.00% |
| Meteora Capital, LLC | 74,651 | $744.0K | 0.19% |
| Westchester Capital Management, LLC | 73,677 | $734.0K | 0.02% |
| Exos TFP Holdings LLC | 63,961 | $638.0K | 0.29% |
| Landscape Capital Management, L.L.C. | 32,248 | $322.0K | 0.04% |
| Elequin Capital LP | 2,800 | $28.0K | 0.01% |
Sold out (6)
Institutions that held Frazier Lifesciences Acquisition Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Spartan Fund Management Inc. | 240,000 | $2.37M |
| Eisler Capital (UK) Ltd. | 206,429 | $2.04M |
| Sagefield Capital LP | 37,700 | $372.0K |
| Centiva Capital, LP | 23,854 | $236.0K |
| Cohanzick Management, LLC | 1,077 | $11.0K |
| Bank of America Corp | 1,022 | $10.0K |
Not filed for Q3 2022 yet (1)
Institutions that held Frazier Lifesciences Acquisition Corp at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exos Asset Management LLC | 64,138 | $633.0K |